Sections, extractions and destructive tests consume stored tissue. Planning several tests requires knowing what material remains and which uses it must support.
NCI biospecimen guidance places pathology oversight of tissue release alongside the need to protect complete medical evaluation. It also treats divided and extracted material as traceable derivative samples. A thoracic small-specimen guideline addresses triage and handling for multiple ancillary studies in its own clinical scope. The general resource issue is finite material, not a universal order of tests: remaining tissue and assay requirements need to be established for the actual specimen.
Shares Tissue preparation and assay suitability, Pre-analytics: blood-collection tubes and tissue fixation, Immune measurements and product evidence.
Shares Immunopeptidomics, Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Pre-analytics: blood-collection tubes and tissue fixation, Immune measurements and product evidence.
Shares Immunopeptidomics, Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Immunopeptidomics, Immune measurements and product evidence.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/